Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples

Publisher： Karger

E-ISSN： 1660-3818|39|6|381-385

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.39, Iss.6, 2012-11, pp. : 381-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients – First Results

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 6, 2012-11 ,pp. : 376-380

Karger

Access to resources Recommend Favorite

Seroconversion of HIV, HCV, and HBV in Blood Donors in 1996 – Risk of Virus Transmission by Blood Products in Germany

By  

Transfusion Medicine and Hemotherapy, Vol. 25, Iss. 2-3, 1998-06 ,pp. : 82-84

Karger

Access to resources Recommend Favorite

Validation of a PCR Assay System to Screen Plasma for HBV, HCV, and HIV-1

By  

Transfusion Medicine and Hemotherapy, Vol. 25, Iss. 2-3, 1998-06 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Infections with HIV, HBV, and HCV among Blood Donors in Germany 1998 and 1999

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 6, 2002-12 ,pp. : 305-307

Karger

Access to resources Recommend Favorite

The final trip: post-mortal mobility in Sweden

By Marjavaara Roger  

Mortality, Vol. 17, Iss. 3, 2012-08 ,pp. : 256-275

Routledge Ltd

Access to resources Recommend Favorite